Stock search

Ticker or company name

CVS card

CVS price forecast

CVS Health$88,59

P/E now is 10,3. Average over 5 years: 31,1 (range 15–31). The stock is 67% below its history.

Base · FY2030

$243,65+32,9% a year

The base case gives 32,9% a year, above your target of 10%.

Settings

%

No analyst consensus: assumptions come from the company's last 5 years. Change any in the table.

Assumptions by year

FY2026FY2027FY2028FY2029FY2030
Revenue growth, %
Net margin, %
Change in shares, %
Payout ratio, %
P/E low
P/E base
P/E high
Revenue$436 bn$472 bn$512 bn$555 bn$602 bn
Net income$6,97 bn$7,55 bn$8,19 bn$8,87 bn$9,62 bn
EPS$5,52$6,02$6,57$7,17$7,82

Changed values are highlighted. Bear and bull cases: growth ∓ 2,7%, margin ∓ 2 pp, low and high P/E.

Price at year end

  • Base
  • Bear – Bull
  • now $88,59

The dot is the base case, the line runs from bear to bull, the dashed line is today's price.

Result at the end of FY2030

Bearn/a (loss)

Base$243,65

Price change
+175,0%
A year
+32,9%
Fair value today
$193,14
Margin of safety
+118,0%

Bull$607,19

Price change
+585,4%
A year
+65,8%
Fair value today
$480,26
Margin of safety
+442,1%

What growth the price implies

For the stock to return 10% a year, revenue must grow −4,2% a year to FY2030 at a 1,6% margin and P/E 31,1.

Growth over 5 years
8,4%
Analyst consensus
no data
In your model
8,4%

Calculated from your assumptions. Not an investment recommendation.

Base · FY2030$243,65+32,9% a year